ASCO HR+/HER2 Breast Review: Practice Changing Monalessa-7 Trial Ribociclib + Endocrine Therapy Superior PFS/OFS in Premenopausal Women & Alpelisib for PIK3 Mutated Advanced Breast Cancer

650 views
August 14, 2019
0 Comments
Login to view comments. Click here to Login